Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

GHLV, ORFG, NST, SON, GS - Stock Report! April 18th 2011

|Includes: BKEN, GS, Kedem Pharmaceuticals, Inc. (KDMP), NST


Global Health Ventures Completes X-Excite Formulation for North American Clinical Trials!
Shares of GHLV increased $0.02 (+38.49%), up to $0.08 in trading, today.
Volume: 7,126,162

Global Health Ventures Inc. (OTCBB:GHLV.OB) is a specialty pharmaceutical company with expertise in drug delivery and formulation. The Company has a proprietary platform technology for drug delivery via the sublingual (under the tongue) route. This unique method delivers drugs to the bloodstream quickly with minimal drug breakdown in the liver or gastrointestinal system, a process that can greatly reduce side effects associated with the drugs.

GHLV completed the final formulation of its lead therapeutics drug, X-Excite for the upcoming clinical trials in the United States. Results of the interim clinical trials in Europe showed X-Excite to appear in the blood rapidly and stay for longer time than the brand, Viagra(NYSE:R). It is believed the longer presence of the drug in the blood may contribute to both buccal (sublingual) absorption and the gastric absorption. For North American trials, the Company has modified the formulation slightly to give the maximal buccal absorption.

Read more at:


Orofino Gold Corp. (PINK OTC:ORFG), a Colombian based gold producer, announced results from random chip samples from within their La Azul mining area in Colombia that indicate very high grades.


* Random chip samples returned high grades to 40.20 grams of gold per tonne in average (or 1.29 troy ounces per tonne) by adopting fusion method (G6Gr).
* Random chip samples returned grades to 107.40 grams of silver per tonne in average (adopting aqua regia digestion method - 7AR).

Read more at: